Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04453046
Title Hemopurifier Plus Pembrolizumab in Head and Neck Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Aethlon Medical Inc.
Indications

head and neck squamous cell carcinoma

oral squamous cell carcinoma

hypopharynx cancer

oropharynx cancer

laryngeal squamous cell carcinoma

Therapies

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.